Last reviewed · How we verify

VN — Competitive Intelligence Brief

VN (VN) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: live, attenuated vaccine. Area: Infectious Disease.

marketed live, attenuated vaccine Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

VN (VN) — Biomedical Advanced Research and Development Authority. Venezuelan equine encephalitis virus (VEEV) vaccine is a live, attenuated vaccine that stimulates an immune response against VEEV.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
VN TARGET VN Biomedical Advanced Research and Development Authority marketed live, attenuated vaccine
VARIVAX® 2016 Commercial Process VARIVAX® 2016 Commercial Process Merck Sharp & Dohme LLC phase 3 Live, attenuated vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (live, attenuated vaccine class)

  1. Biomedical Advanced Research and Development Authority · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). VN — Competitive Intelligence Brief. https://druglandscape.com/ci/vn. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: